Stage 2 encompasses the practical aspects of conducting CKDu studies in the field, including maintaining consistency across sites, ensuring participant protection, and collecting data and samples suitable for the study objectives. The i3C reports emphasize that rigorous implementation is essential for producing interpretable and
comparable results particularly when studies are conducted across diverse regions and resource settings.
Community engagement is integral to CKDu studies, serving as a component of both risk management and scientific rigor. Effective engagement clarifies study objectives, minimizes misconceptions regarding testing, and enhances participant recruitment and retention, especially in contexts where CKDu is associated with occupational and livelihood factors.
Practical approaches include:
- Establishing a local engagement plan that identifies trusted community partners and defines how information will flow both ways during the study.
- Being explicit about uncertainty¾what is known, what remains unknown, and what the study can realistically deliver in the short term.
- Planning in advance how results will be communicated (individual and community-level), and what clinical referral options exist when abnormal findings are detected.
- Avoiding harm from stigma or blame, especially when work practices or environmental exposures are being assessed; this is also crucial when interventions are being considered.
Implementation should prioritize standardization while remaining responsive to local context. The i3C minimum dataset approach is designed to facilitate harmonization across CKDu hotspots, thereby enabling meaningful comparison and pooling of findings where appropriate.
Operational priorities:
- Use clear SOPs for participant screening, repeat testing when needed, and document exclusions for known CKD causes.
- Standardize core clinical measurements (e.g., creatinine/eGFR approach, urine testing, blood pressure), including timing and repeat measurement plans for borderline results.
- Track reasons for missing data and loss to follow-up; this becomes critical when interpreting progression and risk factor findings.
- Align field exposure assessment tools with the etiologic hypothesis and local context.
Biomarkers enhance CKDu studies by enabling early detection of injury, supporting mechanistic hypotheses, and refining phenotyping. However, the i3C reports caution that biomarkers necessitate careful selection, validation, and interpretation across varied populations and laboratory settings.
Implementation guidance:
- Choose biomarkers that match the research question (screening vs mechanistic work vs progression), rather than adding markers “because available”.
- Treat biomarkers as complementary to standardized clinical data¾not as a substitute for robust exposure assessment and kidney function measurement.
- Pre-specify collection timing (e.g., baseline and follow-up points), storage conditions, and analytical plans to reduce post hoc bias.
Laboratory quality frequently represents a critical challenge in multicenter CKDu research. Minor variations in creatinine measurement, urine testing protocols, or sample handling can result in apparent technical discrepancies between study sites.
Key elements to lock down early:
- Standardize creatinine measurement approach and reporting and document any changes over time.
- Use consistent urine testing protocols (dipstick vs quantitative measures where feasible) and record thresholds and units.
- Implement basic quality assurance: calibration procedures, external controls where feasible, and periodic cross-checking between sites.
- Where specialized assays are used (biomarkers, molecular work), maintain chain-of-custody documentation and pre-defined sample acceptance criteria.
Genetic approaches can elucidate susceptibility and refine disease subtypes; however, the i3C reports stress that genetic components must be integrated with careful
consideration of ethical issues and local acceptability, particularly when engaging vulnerable communities.
Practical guidance:
- Define the purpose of genetics up front (susceptibility, ancestry-informed interpretation, gene-environment work) and ensure it aligns with the main study aims.
- Build consent materials that clearly explain what will be tested, what will not be returned, and how samples/data will be stored and shared.
- Plan governance for genetic data, including local oversight and appropriate limits on secondary use.
- Anticipate practical constraints (sample collection, storage, export rules, analytic capacity) and avoid starting genetic components that cannot maintained reliably.
Kidney biopsy offers definitive insights into phenotype and underlying mechanisms, but involves inherent risks and necessitates specialized infrastructure. The i3C position statement recommends that biopsies in CKDu hotspots be conducted as part of a structured program rather than on an ad hoc basis.
Core elements for implementation:
- Include clear indications for biopsy in the study protocol and ensure procedures are performed in settings equipped to carry out the procedure safely and manage complications.
- Standardize tissue handling, processing, and reporting to ensure findings are comparable across sites, and plan for expert review when local capacity is limited.
- Treat pathology as part of the scientific framework: biopsy results should feed back into phenotyping, exposure hypotheses, and biomarker selection¾not seen in isolation.
- Ensure community acceptability and strong consent processes, especially because a biopsy can be perceived as highly invasive or suspicious in some settings.
Biorepositories enhance the long-term value of CKDu studies facilitating future analyses as methodologies advance and new evidence emerge. The i3C reports emphasize the importance of planning and governance, as repositories lacking clear protocols and reliable management may become unusable or present ethical concerns.
Key requirements:
- Define what will be stored (serum, plasma, urine, DNA, tissue), where it will be stored, and under what conditions.
- Establish governance: ownership, access decisions, permitted secondary uses, and data sharing arrangements that respect local priorities.
- Build realistic sustainability plan (power stability, temperature monitoring, inventory systems, staffing, and funding) before collection begins.